Long-term, heavy ketamine use can cause erectile dysfunction, but low-dose medical ketamine appears to carry almost no risk. The distinction comes down to how much you’re using and for how long. Animal studies show that daily high-dose ketamine over one to three months progressively damages the tissue and nerve signaling required for erections, while clinical trial data for prescription esketamine (Spravato) shows erectile dysfunction in 0% of patients.
What Heavy Use Does to Erectile Tissue
The clearest evidence comes from a study published in Oncotarget that gave rats daily high-dose ketamine injections for up to three months. Researchers measured erectile responses at the one-month, two-month, and three-month marks. All ketamine-treated animals showed decreased erectile function, and the decline got worse with time. By three months, erectile responses had dropped significantly compared to controls.
The damage happened through two key pathways. First, ketamine reduced the activity of an enzyme on the cavernous nerve, the nerve responsible for triggering erections. That enzyme produces nitric oxide, the chemical signal that relaxes blood vessels in the penis and allows blood to flow in. After two months of daily ketamine, the nerve’s ability to produce this signal dropped significantly. Second, ketamine caused increased fibrosis (scarring) in the erectile tissue itself by the three-month mark. Scarred smooth muscle tissue can’t expand and fill with blood the way healthy tissue does.
There was also early-stage cell death in the erectile tissue within the first month of exposure. The combination of nerve damage, reduced blood flow signaling, and tissue scarring paints a clear picture of how chronic heavy ketamine use physically impairs erections over time.
Hormonal Effects Add Another Layer
Ketamine’s impact isn’t limited to local tissue. A study on male rats found that chronic ketamine injections significantly decreased testosterone, along with other reproductive hormones including follicle-stimulating hormone and luteinizing hormone. Low testosterone alone can reduce sex drive and make erections harder to achieve or maintain.
The encouraging finding from that study: these hormonal effects disappeared four weeks after the animals stopped receiving ketamine. The researchers described the reproductive harm as “reversible,” suggesting that at least the hormonal component of ketamine-related sexual dysfunction can recover once use stops. Whether the physical tissue damage (fibrosis and nerve changes) reverses as easily is less clear.
Bladder Damage May Make It Worse
Chronic ketamine use is well known for causing bladder problems, sometimes called “ketamine bladder.” This involves painful, frequent urination and inflammation that resembles interstitial cystitis. Research on ketamine users found that those with lower urinary tract symptoms were significantly more likely to also experience sexual dysfunction. The pelvic inflammation and nerve irritation from bladder damage likely contributes to erectile and other sexual problems independently of ketamine’s direct effects on erectile tissue. For heavy users, bladder symptoms and sexual dysfunction often show up together.
Medical Ketamine Tells a Different Story
If you’re receiving ketamine or esketamine through a prescriber for depression, the sexual side effect profile looks remarkably clean. Phase 3 clinical trials of Spravato (esketamine nasal spray) tracked sexual side effects carefully across hundreds of patients. Erectile dysfunction was reported in 0% of patients receiving esketamine, compared to 0.6% in the placebo group. Overall sexual dysfunction of any kind occurred in just 0.2% of the esketamine group. Delayed ejaculation was reported at the same 0.2% rate.
These numbers are strikingly low, especially compared to traditional antidepressants, which commonly cause sexual side effects including difficulty with arousal, delayed orgasm, and reduced desire. In fact, one of the reasons ketamine-based treatments have generated interest for depression is precisely because they avoid the sexual dysfunction that makes many people stop taking SSRIs and SNRIs.
Why Dose and Frequency Matter So Much
The gap between animal study findings and clinical trial data isn’t contradictory. It reflects a massive difference in exposure. The rat studies used daily high-dose injections for months, mimicking the kind of heavy, frequent recreational use that also causes bladder damage and cognitive problems. Medical ketamine, by contrast, is given at much lower doses on an intermittent schedule, often once or twice a week during an initial phase and then tapering to less frequent sessions.
The animal research showed that erectile function declined progressively from month one through month three of continuous daily use, with nerve signaling and tissue quality getting worse at each time point. This pattern suggests a cumulative, dose-dependent process. Occasional low-dose exposure simply doesn’t produce the same sustained assault on nerve function and tissue integrity.
For someone using ketamine recreationally at high doses multiple times a week, the risk of sexual dysfunction is real and supported by both animal evidence and clinical reports. For someone receiving supervised, low-dose treatments for depression or pain, the available data suggests erectile dysfunction is not a meaningful concern. The context of use, not just the substance itself, determines the risk.